TL;DR
- •The tech industry has well-documented elevated rates of anxiety, burnout, and depression — driven by always-on culture, layoff cycles, and the gap between perceived and actual job security.
- •On-call rotations, sprint pressure, and remote-work isolation compound the chronic-stress load — many tech workers describe "feeling exhausted but unable to actually rest."
- •Telehealth ketamine therapy fits the tech work pattern — no clinic visits, sessions scheduled around standups and on-call, completely private from employer systems.
- •Tovani is direct-pay ($349/month, HSA/FSA eligible) — bypasses any insurance-claim record that might surface in benefits administration.
- •Many tech workers come to Tovani after multiple SSRI trials that produced "feeling flat" or "emotional blunting" without solving the underlying anxiety/depression. Ketamine's different mechanism (NMDA/glutamate) often works where serotonin-focused drugs didn't.
- •Sessions can be done on weekends or PTO days; the antidepressant effect is measurable within hours and persists between sessions.
The stressors specific to your work
- •Always-on culture (Slack/PagerDuty/on-call) that prevents real disconnection
- •Layoff anxiety and the "next round" psychological overhead
- •Sprint deadlines that compress recovery time
- •Remote-work isolation and reduced incidental social contact
- •Imposter syndrome amplified by visible-to-everyone skill rankings (Leetcode, GitHub, etc.)
- •Compensation tied to vesting cliffs that punish leaving when burned out
Why telehealth works for tech workers
- •No clinic visits — fits between sprints, on-call shifts, and standups
- •Sessions scheduled evenings or weekends; can use PTO without explaining
- •Completely separate from employer healthcare system or EAP
- •Same physician every visit — no rotating panel
- •Works for remote workers anywhere in FL or NJ
Privacy considerations
- •Tovani is direct-pay — no insurance claim is filed unless you submit for reimbursement.
- •No clinic visits means no medical-office record that might cross-reference with benefits systems.
- •Medication arrives in discreet packaging.
- •Patient records are protected by HIPAA and not shared with employers or insurers except as required by law.
5-minute screening · Reviewed by a board-certified physician · FL & NJ · $349/month
Frequently asked
Will my employer or HR find out?
No — Tovani is direct-pay. There's no insurance claim filed unless you submit one yourself for HSA/FSA reimbursement, and even then the claim only includes the line item, not the underlying clinical detail. There's no clinic visit that might cross-reference with employer-side benefits systems. Patient records are HIPAA-protected and not shared with employers.
I've tried Lexapro, Zoloft, and Wellbutrin without much help. What now?
After multiple adequate antidepressant trials, you meet the technical criteria for treatment-resistant depression. Ketamine's mechanism (NMDA receptor antagonism + glutamate signaling) is completely different from any SSRI, SNRI, or NDRI — so patients who haven't responded to multiple serotonin/norepinephrine drugs often do respond to ketamine. Published response rates in treatment-resistant cases are 60-70% within hours of the first session.
I'm on-call. Can I take ketamine during call weeks?
No — you should not be on-call during a session day or for 24 hours after. Plan sessions around your on-call schedule (e.g., the week after you rotate off). Most patients do sessions 1-2x per week during the initial 4-6 week course, which means working it around 4-8 sessions across about 6 weeks.
What about my visa or H-1B?
Outpatient mental health treatment is not a routine disclosure item on visa or H-1B paperwork. Tovani is direct-pay; there's no automatic third-party record. If you have specific immigration concerns about a treatment, consult an immigration attorney — but standard outpatient telehealth care is not typically a flag.
Can I keep working while on ketamine therapy?
Yes — outside the 4-5 hour session window, cognitive function is normal or better. Most tech-worker patients report improved focus, less rumination, and clearer thinking within the first few sessions. The antidepressant effect typically removes cognitive symptoms of depression (slow thinking, difficulty concentrating) rather than adding new impairments.
References
- Murrough JW et al. 2013, American Journal of Psychiatry. Ketamine RCT showed 64% response in treatment-resistant depression — relevant for the SSRI-resistant subset commonly seen in tech-worker presentations. PMID 23982301
- Sanacora G et al. 2017, JAMA Psychiatry. APA consensus on ketamine's rapid antidepressant effects across complex psychiatric presentations including burnout-driven depression. PMID 28249076